ARCHIVES

Two Phase II Trials Display Ramucirumab Potential Efficacy

This article is from The Cancer Letter archive.

Vol. 35 No. 10 | October 26, 2012

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

September 13, 2002

ASCO Defines Clinically Meaningful Outcomes

April 25, 2013

In Brief : Three Named To Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

July 11, 2014

Radiation Oncology To Become Crowded, ACR Warns Physicians

December 15, 1995

St. Jude Children’s Research Hospital Wins NCI Designation As Comprehensive.

May 16, 2008

DCPC Board Okays Core Grant Changes On Shared Resources

January 30, 1987